The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis
Published version of a preprint
Abstract
Purpose: Fusobacterium nucleatum (F. nucleatum) is a component of the human microbiome that primarily inhabits the oral cavity. It causes periodontal disease and has also been implicated in the development of human cancers. Although there are several reports of the relationship between F. nucleatum and the clinical outcome in human cancers, its prognostic significance in esophageal cancer remains unclear. Experimental Design: We quantified F. nucleatum DNA in 325 resected esophageal cancer specimens by qPCR. Significant pathways in F. nucleatum–positive esophageal cancer tissues were identified by Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis using microarray data. Results: Esophageal cancer tissues contained significantly more F. nucleatum DNA than matched normal esophageal mucosa (P = 0.021; n = 60). F. nucleatum DNA was detected in 74 of 325 cases (23%). F. nucleatum DNA positivity was significantly associated with tumor stage, but not with sex, age, performance status, tobacco use, alcohol use, histology, tumor location, or preoperative treatment. F. nucleatum DNA positivity was also significantly associated with cancer-specific survival [log-rank P = 0.0039; univariate HR = 2.01; 95% confidence interval (CI), 1.22–3.23; P = 0.0068; multivariate HR = 1.78; 95% CI, 1.06–2.94; P = 0.031]. The top-ranked KEGG pathway in F. nucleatum–positive tissues was “cytokine–cytokine receptor interaction.” A significant relationship between F. nucleatum and the chemokine CCL20 was validated by IHC. Conclusions: F. nucleatum in esophageal cancer tissues was associated with shorter survival, suggesting a potential role as a prognostic biomarker. F. nucleatum might also contribute to aggressive tumor behavior through activation of chemokines, such as CCL20. Clin Cancer Res; 22(22); 5574–81. ©2016 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fusobacterium spp. is important in the development and progression of gastrointestinal tumors1,19,34,35”
From RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach (2020) · cites this paper as [34]
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,613
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
Cited by
Sorted by citations
Items 401–456 of 456
Zeng, H., Liu, H., Yang, F., & Li, J. R. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1829524 · Cited by 1
Li, X., Zuo-Quan, X., & Geng, M. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01882-x · Cited by 1
Esophageal microbiota and esophageal diseases
Ma, S., Wang, S., Zhu, L., Chen, X., & Wang, B. (2019) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v27.i12.767 · Cited by 1
Sogawa, Y., Fukui, M., Nakamura, S., Sogabe, K., Sumitani, R., Yoshioka, M., Abe, M., & Hinode, D. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-02975-x · Cited by 1
Theodoropoulos, G. E. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_4 · Cited by 1
Zuo, J., Liu, Y., Lv, W., Wang, Y., Fan, Z., Wang, L., Li, F., Zhang, X., Han, J., & Ni, Z. (2022) · Protein & Cell · doi:10.1093/procel/pwac024 · Cited by 1
Liver Abscesses Due to Fusobacterium nucleatum
Elkhapery, A. M. R., Malik, S., Chaudhary, P., Abdalla, Z., Niu, C., Jain, T., Low, S. K., Abdelhay, A., Portales-Castillo, C., Ali, O. A., et al. (2023) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001326 · Cited by 1
Microbiome: Its Impact Is Being Revealed!
El‐Jurdi, N., Lima, M. J. G. D., Lazarus, H. M., & Ghannoum, M. A. (2017) · Current Clinical Microbiology Reports · doi:10.1007/s40588-017-0063-9 · Cited by 1
大腸癌における腸内細菌研究の動向 ― Fusobacterium nucleatum による大腸癌研究の新しい潮流―
吉原, 努., 中島, 淳., 野上, 麻., Takatsu, T., 三澤, 昇., 芦苅, 圭., 松浦, 哲., 冬木, 晶., 大久保秀則, & 日暮, 琢. (2021) · doi:10.11209/jim.35.1 · Cited by 1
Diagnostic and Therapeutic Uses of the Microbiome in the Field of Oncology
Anipindi, M., & Bitetto, D. (2022) · Cureus · doi:10.7759/cureus.24890 · Cited by 1
Fusobacterium Nucleatum Predicts a Risk for Esophageal Squamous Cell CarcinomaPreprint
Shi, C., Li, Z., Zheng, J., Kong, W., Fan, T., Jian, D., Cheng, X., Zhao, H., Ma, J., Tang, H., et al. (2020) · doi:10.21203/rs.3.rs-101163/v1 · Cited by 1
Role of Infectious Agents on Development of Esophageal Carcinomas
Whelan, K. A., & Nakagawa, H. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_3
Pathophysiologie des Adenokarzinoms am ösophagogastralen Übergang (AEG)
Liotta, L., & Quante, M. (2019) · Der Onkologe · doi:10.1007/s00761-019-00666-9
Biofilm-mediated Gastrointestinal Diseases
Nayak, S. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-30757-8_12
Epidemiological Perspectives of Human Health Through Metagenomic Research
Singh, H., Sharma, I., & Sharma, V. (2020) · Springer eBooks · doi:10.1007/978-981-15-6529-8_9
Biomarkers of Esophageal Cancers and Precancerous Lesions
Bajpai, M., & Zhou, Z. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_5
Takahashi, N., & Tabeta, K. (2021) · 日本歯周病学会会誌 · doi:10.2329/perio.63.151
Zhang, X., Zhang, Y., Gui, X., Zhang, Y., Zhang, Z., Zhang, X., Chen, W., Zhang, X., Wang, Y., Zhang, M., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3975353
Du, J., Qiao, H., & Xie, D. (2022) · All Life · doi:10.1080/26895293.2022.2046653
Ponath, F., Zhu, Y., Cosi, V., & Vogel, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.29.501972
Role of Animal Models in the Development of Bacteria-Based Live Therapeutics to Fight Cancer
Tata, K., Ramadevi, S., Shelin, R., & Meenakshi, S. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_7-1
Role of Animal Models in the Development of Bacteria-Based Live Therapeutics to Fight Cancer
Tata, K., Ramadevi, S., Shelin, R., & Meenakshi, S. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_7
Host–Microbiome Interactions in Gastrointestinal Cancers
Sun, J. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_10
Zhou, X., Su, W., Chen, H., Ye, B., Si, X., Zhang, W., Li, X., & Zhang, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3149703/v1
Elwakil, B. H., & El‐Naggar, M. Y. (2024) · Springer eBooks · doi:10.1007/978-3-030-80962-1_382-1
Advancements in Cancer Immunotherapy: Exploring Treatment OptionsPreprint
Ahuja, S., Aden, D., Zaheer, S., Sureka, N., & Zaheer, S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4893598
Esophageal Cancer and Infections
Köse, Ş., & Özgüler, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-47024-0_34
Microbiota in cancer diagnosis, therapy and prevention
Геннадьевна, С. Л., Рыжова, Н. И., Belitsky, G. A., Antonova, I., Игоревич, К. К., & Геннадиевна, Я. М. (2024) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2024-23-4-10-21
Cancer and microbiome-targeted therapies
Meena, A. S., Singh, P., & Shukla, P. K. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.006
Xie, J., Zhu, N., & Xu, W. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1513270
Esophageal microbiome correlates with post-esophagectomy anastomotic leak in cancer patients
Naddaf, R., Shmilovich, H., Carasso, S., Keshet-David, R., Herren, R., Gefen, T., Goshen‐Lago, T., Zwang, Y., Livyatan, I., Shental, N., et al. (2025) · ESMO Gastrointestinal Oncology · doi:10.1016/j.esmogo.2025.100172
Bai, L., & Zhu, A. (2025) · Advanced Biology · doi:10.1002/adbi.202400823
Microbial overlap in dental plaque and tumor tissue of esophageal cancer patients: A pilot study
Gupta, S., Angrup, A., Rana, S. S., Batra, G., Rana, N., Ramola, M., Vashist, T., Bisht, K., Monga, N., Jolly, S. S., et al. (2025) · Journal of Indian Society of Periodontology · doi:10.4103/jisp.jisp_412_24
Applying principles of vaccine development to oncomicrobial vaccines
Despins, C. A., Viegas, N. J., & Holt, R. A. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015610
El-Hadedy, D. E., Moran, G. P., & Al-Hebshi, N. N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.01.679755
Elwakil, B. H., & El‐Naggar, M. Y. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_382
Helicobacter pylori in esophageal carcinogenesis: Potential culprit or forceful defender?
Ren, D., Cui, M., Yang, D., Zhang, Y., Hao, Y., Yue, Y., Wei, B., Fan, Q., Sun, C., Li, Q., et al. (2025) · Virulence · doi:10.1080/21505594.2025.2580749
Yoshikawa, T., Nishi, H., Emi, M., Hamai, Y., Ibuki, Y., Kurokawa, T., Hirohata, R., Ohsawa, M., Kitasaki, N., Komatsuzawa, H., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336219
Li, S., Wang, T., Ren, Y., Liu, Z., Gao, J., & Guo, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26672982
Li, Z., Shi, C., Zheng, J., Guo, Y., Fan, T., Zhao, H., Jian, D., Cheng, X., Tang, H., & Ma, J. (2021) · Figshare · doi:10.6084/m9.figshare.16909587
Li, C., Ma, J., & Wang, N. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003852
Tahara, T., Shijimaya, T., Yamazaki, J., Shimogama, T., Kobayashi, S., Nakamura, N., Takahashi, Y., Tomiyama, T., Fukui, T., Shibata, T., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-45806-5
Guo, S., Chen, X., Wei, M., Yang, F., Jiang, S., Zhao, L., Hu, L., Li, Z., & Shen, X. (2026) · Biomedicines · doi:10.3390/biomedicines14051062
Hadjigol, S., Shah, B. A., Yazdani, N., & O’brien-simpson, N. M. (2026) · Cells · doi:10.3390/cells15100855
Becker, J., Mertens, A., Rieger, M. D., Conrads, G., & Rezasoltani, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114865
Whole Mouth Fluid Microbiome: A New Frontier in Cancer Research
Gopinath, D., Issa, A. W., Liu, J., & Li, Z. (2026) · Current Oral Health Reports · doi:10.1007/s40496-026-00434-w
Shi, R., Zhi, Y., Gao, L., Li, S., Ren, W.-H., & Zhi, K. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000005480
Shi, R., Zhi, Y., Gao, L., Li, S., Zhi, K.-Q., & Ren, W. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70723
Wang, Y., Lian, X., Chen, Y., & Wang, F. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004194
Fusobacterium nucleatum in cancer: prognostic relevance and clinical implications
Lehr, K., Thon, C., & Link, A. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102124
Fan, Q., Zhang, R., Xu, D., Wen, F., Xu, W., & Liu, H. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-05074-z
The role of adhesins of Fusobacterium nucleatum in colorectal cancer – a structural perspective
Schöpf, F., Marongiu, G. L., & Roderer, D. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2709265
Huhtala, J.-M., Buaoud, M. M., Musrati, A. A., Piiparinen, K., Suominen, A., Haglund, C., Hagström, J., & Willberg, J. (2026) · International Journal of Dentistry · doi:10.1155/ijod/5994390
金米拉, Yang, Q., Qin, J., Zhao, D., Zhang, S., Wang, Z., Chen, L., Zhao, H., Nuerbieke, T., Tian, H., et al. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02499-x
Intratumoral Microbiota in Fueling Cancer and Steering Treatment Response
Xu, M., Yu, J., Chen, Y., Ge, S., Ye, L., Wang, Y., 周一雄, & Jia, R. (2026) · MedComm · doi:10.1002/mco2.71052
Cheng, S., Zhang, Y., Li, W., Xu, G., & Qu, J. (2026) · Biomedicines · doi:10.3390/biomedicines14112485
Metadata
- Authors
- Yamamura, K., Baba, Y., Nakagawa, S., Mima, K., Miyake, K., Nakamura, K., Sawayama, H., Kinoshita, K., Ishimoto, T., Iwatsuki, M., Sakamoto, Y., Yamashita, Y., Yoshida, N., Watanabe, M., & Baba, H.
- Affiliations
- Kumamoto University (JP)
- 1Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- The Cancer Institute Hospital (JP)
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2016-11-14
- Volume
- 22
- Issue
- 22
- Pages
- 5574-5581
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2537571631
- Cited by
- 457
- References
- 50
- Citations by year
- 2026: 33 · 2025: 68 · 2024: 70 · 2023: 60 · 2022: 51 · 2021: 69 · 2020: 54 · 2019: 24 · 2018: 11 · 2017: 16
- FWCI
- 18.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Fusobacterium nucleatum, esophageal cancer, gut microbiota, prognostic factors, cancer-specific survival, tumor stage, CCL20, cytokine-cytokine receptor interaction, chemokines, tumor microenvironment, periodontal disease
- MeSH terms
- Aged, DNA, Bacterial, Esophageal Neoplasms, Female, Humans, Male, Prognosis, Fusobacterium nucleatum, Chemokines, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
